Research Article
3,5-Dinitrobenzoate and 3,5-Dinitrobenzamide Derivatives: Mechanistic, Antifungal, and In Silico Studies
Table 4
Physicochemical and ADMET predictions for compound 2 and nystatin.
| | Parameters | Compound 2 | Nystatin |
| | Physicochemical properties | | Molecular weight (g/mol) | 240.17 | 926.09 | | Rotatable bonds | 5 | 3 | | H-bond acceptors | 6 | 18 | | H-bond donors | 0 | 12 | | Fraction Csp3 | 0.22 | 0.7 | | TPSA (A3) | 117.94 | 319.61 |
| | Toxicity | | AMES toxicity | Yes | No | | Max. Tolerated dose (human, log(mg/kg/day)) | 0.003 | 0.281 | | hERG I inhibitor | No | No | | hERG II inhibitor | No | No | | Oral rat acute toxicity (LD50, mol/kg) | 2.721 | 2.518 | | Oral rat chronic toxicity (LOAEL, log(mg/kg_bw/day)) | 1.439 | 2.035 | | Hepatotoxicity | No | No | | Skin sensitization | No | No |
|
|